United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market (2025-2031) | Companies, Share, Analysis, Competitive Landscape, Growth, Trends, Outlook, Industry, Forecast, Size & Revenue, Value, Segmentation

Name: United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Application (Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies), By Indication (Infectious Diseases, Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases) And Competitive Landscape

Product Code: ETC9979910	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Outlook
Market Size of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market, 2024
Forecast of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market, 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Revenues & Volume for the Period 2021- 2031
United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Trend Evolution
United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Drivers and Challenges
United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Price Trends
United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Porter's Five Forces
United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Industry Life Cycle
Historical Data and Forecast of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume By Application for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume By Viral Vaccines for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume By Protein Replacement Therapies for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume By Cancer Immunotherapies for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume By Indication for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume By Metabolic & Genetic Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume By Cardiovascular & Cerebrovascular Diseases for the Period 2021- 2031
United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Import Export Trade Statistics
Market Opportunity Assessment By Application
Market Opportunity Assessment By Indication
United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Top Companies Market Share
United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Competitive Benchmarking By Technical and Operational Parameters
United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Company Profiles
United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market - Industry Life Cycle

3.4 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market - Porter's Five Forces

3.5 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume Share, By Indication, 2021 & 2031F

4 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investment in mRNA therapeutics research and development

4.2.2 Growing prevalence of genetic diseases and chronic conditions driving demand for mRNA therapeutics

4.2.3 Advancements in mRNA technology leading to more efficient and targeted therapies

4.3 Market Restraints

4.3.1 Regulatory challenges and uncertainties around mRNA therapeutics

4.3.2 High costs associated with mRNA therapeutics development and manufacturing

4.3.3 Limited expertise and infrastructure for mRNA therapeutics manufacturing in the US

5 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Trends

6 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Types

6.1 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Application

6.1.1 Overview and Analysis

6.1.2 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Viral Vaccines, 2021- 2031F

6.1.4 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Protein Replacement Therapies, 2021- 2031F

6.1.5 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Cancer Immunotherapies, 2021- 2031F

6.2 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.2.3 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Metabolic & Genetic Diseases, 2021- 2031F

6.2.4 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Cardiovascular & Cerebrovascular Diseases, 2021- 2031F

7 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Import-Export Trade Statistics

7.1 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Export to Major Countries

7.2 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Imports from Major Countries

8 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Key Performance Indicators

8.1 Number of new mRNA therapeutics entering clinical trials

8.2 Percentage increase in RD funding for mRNA therapeutics

8.3 Adoption rate of mRNA therapeutics in treating various diseases

9 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market - Opportunity Assessment

9.1 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Opportunity Assessment, By Indication, 2021 & 2031F

10 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market - Competitive Landscape

10.1 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenue Share, By Companies, 2024

10.2 United States (US) mRNA Therapeutics Contract Development & Manufacturing Organization Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa mRNA Therapeutics Contract Development & Manufacturing Organization Market

Equatorial Guinea mRNA Therapeutics Contract Development & Manufacturing Organization Market

Eritrea mRNA Therapeutics Contract Development & Manufacturing Organization Market

Estonia mRNA Therapeutics Contract Development & Manufacturing Organization Market

Ethiopia mRNA Therapeutics Contract Development & Manufacturing Organization Market

Fiji mRNA Therapeutics Contract Development & Manufacturing Organization Market

Global mRNA Therapeutics Contract Development & Manufacturing Organization Market

Middle East mRNA Therapeutics Contract Development & Manufacturing Organization Market

North America mRNA Therapeutics Contract Development & Manufacturing Organization Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here